BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
340.61
-0.03 (-0.01%)
At close: Nov 28, 2025, 1:00 PM EST
337.96
-2.65 (-0.78%)
After-hours: Nov 28, 2025, 4:59 PM EST

BeOne Medicines AG Revenue

BeOne Medicines AG had revenue of 10.28B CNY in the quarter ending September 30, 2025, with 46.28% growth. This brings the company's revenue in the last twelve months to 35.59B, up 53.47% year-over-year. In the year 2024, BeOne Medicines AG had annual revenue of 27.81B with 59.51% growth.

Revenue (ttm)
35.59B CNY
Revenue Growth
+53.47%
P/S Ratio
7.35
Revenue / Employee
3,235,022 CNY
Employees
11,000
Market Cap
37.69B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202427.81B10.38B59.51%
Dec 31, 202317.43B7.67B78.53%
Dec 31, 20229.77B2.29B30.69%
Dec 31, 20217.47B5.46B270.56%
Dec 31, 20202.02B-965.08M-32.37%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings